期刊文献+

晚期肝癌化疗结合骨髓间充质干细胞输注疗效观察 被引量:2

The efficiency of using chemical therapy combining with MSC to advanced hepatic carcinoma
下载PDF
导出
摘要 目的:评价化疗结合骨髓间充质干细胞输注对晚期肝癌的疗效。方法:取晚期肝癌患者45例,随机分成治疗组(30例)及对照组(15例),均采用相同的化疗方法案后,治疗组加用骨髓间充质干细胞(1.8×10^4/kg),观察疗效及生存率。结果:治疗后1年、2年的肿瘤局部有效率分别为90%,60%。1~2年生存率分别为90%,30%,中位生存期15个月。结论:化疗结合骨髓间充质干细胞输注是治疗晚期肝癌的有效治疗手段。 Objective: To evaluate the efficiency of using chemical therapy combining with MSC to advanced hepatic carcinoma. Methods :Treatment group (30 patients) was adopted MSC after the chemical therapy,while control group (15 patients) only adopted the chemical therapy,then observing curative effect and survival rata. Results:One year after treating finally the partly effective was 90%,60 %, 1 - 2 years survival rate respectively is 90%, 30 %. Median life span is 15 months. Conclusion:To treat advanced hepatic carcinoma with chemical therapy combining with MSC is an effectively method.
出处 《临床医药实践》 2009年第5期327-329,共3页 Proceeding of Clinical Medicine
关键词 肝癌 化疗 骨髓间充质干细胞 advanced hepatic carcinoma chemical therapy MSC
  • 相关文献

参考文献8

  • 1孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,1996.138.
  • 2施小凤,傅晋翔,李军,陈萍,袁育青,黄海雯,孙谕.间充质干细胞联合输注促进造血干细胞移植后的造血重建[J].中华器官移植杂志,2005,26(7):411-414. 被引量:12
  • 3Chapei A,Bertho J M,Bensidhoum M ,et al. Mesenchymal stem cells home to injued tissues when CO-infused with hematopoietic cells to treat a radiation induced multiorgan failure syndrome [J]. Gene Med,2003,5:1 028-1 038.
  • 4Krampera M,Olennie S Dyson J,et al. Bone marrow mesenchymal stem cells inhibit the response of native and memory antigen-specific T cells to their cognate peptide [J]. Blood, 2003,101 : 3 722-3 729.
  • 5Plumas J, Chaperotl, Richard M J, et al. Mesenchymal stem cells induce apoptosis of activated T cells [J]. Leukemia,2005,19(9) :1 597-1 604.
  • 6彭亮,高志良.骨髓间充质干细胞研究现状和在肝脏疾病中的应用[J].国外医学(内科学分册),2006,33(1):14-17. 被引量:5
  • 7朱金水.胃癌的治疗现状[J].中国临床医学,2004,11(2):131-134. 被引量:29
  • 8Taieb J, Bonyhay L,Golli L, et al. Gemcitabine plus oxaliplatin for patients with advanced hepalocellular carcinoma using two different schedules[J]. Cancer, 2003,98(12) :2 664.

二级参考文献27

共引文献211

同被引文献34

  • 1Garth L Warnock.Mesenchymal stem cell-mediated cancer therapy: A dualtargeted strategy of personalized medicine[J].World Journal of Stem Cells,2011,3(11):96-103. 被引量:7
  • 2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 3Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complextissues that interface with the entire organism[J]. Dev Cell, 2010, 18(6): 884-901.
  • 4Hung SC, Deng WP, Yang WK, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging[J]. Clin Cancer Res, 2005, 11(21): 7749-7756.
  • 5Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment[J]. Cancer Metastasis Rev, 2010, 29(2): 249-261.
  • 6Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans[J]. Hepatology, 2000, 32(1): 11-16.
  • 7Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium[J]. Gastroenterology, 2001, 120(2): 534-544.
  • 8Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells[J]. J Clin Invest, 2002, 109(10): 1291-1302.
  • 9Amer ME, E1-Sayed SZ, EI-Kheir WA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells[J]. Eur J Gastroenterol Hepatol, 2011, 23(10): 936-941.
  • 10Li GC, Ye QH, Xue YH, et al. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line[J]. Cancer Sci, 2010, 101(12): 2546-2553.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部